This article is more than 5 years old. Information may no longer be current.

VIDEO: STAMPEDE shows promising results at 5-year mark

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

CHICAGO — In this video, Philip Schauer, MD, director of the Cleveland Clinic Bariatric and Metabolic Institute, discusses 5-year results of the STAMPEDE trial, which compared gastric bypass and sleeve gastrectomy with intensive medical therapy in patients with mild to moderate obesity and type 2 diabetes.

At 5 years, the primary endpoint of HbA1c 6% was reached by 30% of patients who underwent gastric bypass and 23% who underwent sleeve gastrectomy compared with 5% of patients who received medical therapy, according to Schauer. Most patients in the surgery groups no longer required diabetes or CV medications, he said. There were no perioperative deaths related to surgery.

‘This study shows that the effects of metabolic surgery — gastric bypass and sleeve gastrectomy — are quite impactful on type 2 diabetes,” he said.